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Abstract
Mitochondrial disorders are heterogeneous, showing variable presentation and pen‐
etrance. Over the last three decades, our ability to recognize mitochondrial patients 
and diagnose these mutations, linking genotype to phenotype, has greatly improved. 
However, it has become increasingly clear that these strides in diagnostics have not 
benefited all population groups. Recent studies have demonstrated that patients 
from genetically understudied populations, in particular those of black African herit‐
age, are less likely to receive a diagnosis of mtDNA disease. It has been suggested 
that haplogroup context might influence the presentation and penetrance of mtDNA 
disease; thus, the spectrum of mutations that are associated with disease in different 
populations. However, to date there is only one well‐established example of such an 
effect: the increased penetrance of two Leber's hereditary optic neuropathy muta‐
tions on a haplogroup J background. This paper conducted the most extensive in‐
vestigation to date into the importance of haplogroup context on the pathogenicity 
of mtDNA mutations. We searched for proven human point mutations across 726 
multiple sequence alignments derived from 33 non‐human species absent of disease. 
A total of 58 pathogenic point mutations arise in the sequences of these species. We 
assessed the sequence context and found evidence of population variants that could 
modulate the phenotypic expression of these point mutations masking the patho‐
genic effects seen in humans. This supports the theory that sequence context is in‐
fluential in the presentation of mtDNA disease and has implications for diagnostic 
practices. We have shown that our current understanding of the pathogenicity of 
mtDNA point mutations, primarily built on studies of individuals with haplogroups 
HVUKTJ, will not present a complete picture. This will have the effect of creating a 
diagnostic inequality, whereby individuals who do not belong to these lineages are 
less likely to receive a genetic diagnosis.
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1  | INTRODUC TION
Mitochondria are involved in a range of cellular functions such as 
apoptosis and cell death, calcium buffering and the generation of 
ATP by oxidative phosphorylation. Mitochondrial DNA (mtDNA) is 
a circular chromosome comprising of ~16 kbp and encodes 13 pro‐
teins, 22 tRNAs and 2 rRNAs. Cells contain hundreds or even thou‐
sands of copies of mtDNA. In cells or tissues where the mtDNA is 
homoplasmic, all mitochondrial genomic sequences are the same, 
which is the expected state. However, it is possible for more than 
one mtDNA genotype to exist. When we see two mtDNA genotypes 
in individual cells or a tissue type, this is a state known as hetero‐
plasmy (Tuppen, Blakely, Turnbull, & Taylor, 2010). Patients with 
mitochondrial disorders normally exhibit heteroplasmy, where one 
of the genotypes in an mtDNA species has a pathogenic mutation. 
Commonly, a biochemical defect will become apparent if the num‐
ber of mutated sequences accounts for ≥60% of the mitochondrial 
genomic content, known as the threshold effect (Wallace & Chalkia, 
2013). It is estimated that the prevalence of mitochondrial disorders 
is ~1/4,300 within the adult European population and over 2/3 of 
these will be due to an mtDNA mutation (Gorman et al., 2015).
Mitochondria are inherited solely down the maternal lineage 
and, therefore, do not undergo bi‐parental recombination (Elson et 
al., 2001). This has the effect that the evolution of mtDNA is defined 
by the emergence of distinct lineages called haplogroups. Databases 
such as MitoMap and Phylotree have compiled a wealth of infor‐
mation regarding human haplogroup lineages, mtDNA variation and 
disease association (Lott et al., 2013; Oven & Kayser, 2009). It should 
be noted that mtDNA accumulates single nucleotide variants (SNVs) 
at a higher rate than nuclear DNA (Song et al., 2005). This is useful 
for those looking at population histories as a sufficient phylogenetic 
signal can accumulate to study population histories (Howell, Elson, 
Howell, & Turnbull, 2007). However, all this variation presents chal‐
lenges in the linkage of genotype to phenotype in the context of 
mtDNA disease.
Over the years, there has been considerable debate about the 
best way to link genotype to phenotype. The Yarham et al. (2011) 
pathogenicity scoring system is a well‐recognized, widely used sys‐
tem in the mitochondrial community. It is weighted towards func‐
tional studies, namely cybrid and single fibre analysis, which can 
clearly link genotype to phenotype (Yarham et al., 2011). MitoTip is 
a new tool by MitoMap designed to provide an initial pathogenicity 
prediction for newly identified variants. It utilizes a frequentist and 
evolutionary approach, taking three key observations into account: 
variant history and conservation; variant location; and disruption to 
the secondary structure (Sonney et al., 2017).
Mitochondrial disorders have been most widely studied in pa‐
tients with Caucasian European haplogroups and, whilst haplogroup 
divergence allows the opportunity to study global migration pat‐
terns, lack of knowledge of phylogenetic diversity in non‐Caucasian 
and non‐European haplogroups might reduce the accuracy of clini‐
cal diagnosis in these populations (van der Westhuizen et al., 2015). 
Previous research in Black South African populations has shown 
discrepancies in the rate of diagnosis in the context of disease arising 
from mtDNA mutations (van der Westhuizen et al., 2015). This may 
be because either the pathogenic mutations or their presentation 
differs from those found in Caucasian Europeans. The phenotypic 
presentation of mitochondrial disease is also thought to differ be‐
tween populations (Smuts et al., 2010) suggesting there is much still 
to learn about this group of diseases globally (van der Walt et al., 
2012; van der Westhuizen et al., 2015). Here, additional evidence 
to support the importance of mitochondrial sequence context in 
the expression and penetrance of pathogenic mtDNA mutations is 
presented.
One means of exploring the impact of mtDNA sequence context 
is the use of sequences from non‐human species. If a non‐human 
animal that does not exhibit symptoms of mitochondrial disease har‐
bours a proven point mutation associated with disease in humans, 
then exploring the surrounding sequence context of these species 
may give insight into the importance of haplogroup context in the 
presentation and manifestation of this group of mutations.
Previous research has suggested disease‐associated point muta‐
tions are likely to be found in non‐human species without the pres‐
ence of disease. Magalhães (2005) searched a panel of consensus 
sequences from 12 primates and discovered a total of 46 human 
“disease‐associated” mutations across the mitochondrial genomes 
of these species (Magalhães, 2005). Similarly, Kern and Kondrashov 
(2004) focused on the mt‐tRNA genes and compiled single se‐
quences from 106 species. They identified 52 pathogenic mutations 
across the mt‐tRNAs and proposed four mechanisms for masking 
pathogenic mutations that fall in the stem regions of the molecules. 
However, both of these studies were conducted prior to the exis‐
tence of an accepted methodology to link genotype to phenotype in 
the context of mtDNA disease. Thus on re‐evaluation, the evidence 
to support a link between the variants/mutations they reported and 
disease in humans was often weak.
More recently, Queen, Steyn, Lord, and Elson (2017) performed 
a much larger study utilizing multiple sequence alignments from 
33 non‐human species. This more recent study also applied an ac‐
cepted inclusion criterion for the pathogenic variants (Yarham et 
al., 2011). Queen et al. (2017) focused on the m.3243A > G mu‐
tation which is the most prevalent mitochondrial point mutation 
causing disease in humans. It is a common cause of mitochondrial 
myopathy, encephalopathy, lactic acidosis and stroke‐like episodes 
(MELAS) amongst other phenotypes. Queen et al. (2017) studied 
the mt‐tRNA‐LEU(UUR) gene which is affected by the m.3243A > G 
mutation and found this pathogenic mutation was present amongst 
sequences from the dog (Canis lupus familiaris). Further exploration 
of the mt‐tRNA‐LEU(UUR) gene revealed two variants which change 
a G:U Wobble base pair and a mismatch pair to Watson‐Crick like 
pairs within the D‐stem. These changes to the secondary structure 
could mask the pathogenic effects of m.3243A > G in this species.
Four more pathogenic point mutations from mt‐tRNA‐LEU(UUR) 
were also identified in a selection of the non‐human species and, like 
m.3243A > G, evidence of potential masking variants was present 
(Queen et al., 2017). Subsequently, O'Keefe, Queen, Meldau, Lord, 
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and Elson (2018) searched across the seven mitochondrial complex 
I protein‐encoding genes of the same 33 species. Again, pathogenic 
point mutations were found; however, at a much lower frequency. 
Three proven pathogenic point mutations were found across the 
seven genes of complex I, in contrast to the five point mutations in 
a single mt‐tRNA gene. Only one of the three mutations observed in 
the protein‐encoding genes m.3308T > C, exhibited its disease‐asso‐
ciated amino acid change as seen in humans.
Furthermore, the evidence supporting pathogenicity of this mu‐
tation is debated, particularly surrounding its role in left ventricular 
hypertrabeculation/noncompaction (Salas & Elson, 2012). This con‐
trasting finding suggests that sequence context may be of less im‐
portance in the presentation and penetrance of mtDNA mutations in 
mt‐protein‐encoding genes (O'Keefe et al., 2018). One explanation 
is the differential strength of purifying selection in these genes. In 
murine models, changes in the protein‐encoding genes are rapidly 
eliminated, but changes in the mt‐tRNAs persist for many more gen‐
erations (Kauppila et al., 2016; Stewart et al., 2008). This phenome‐
non could help maintain interactions between the mitochondrial and 
nuclear proteins responsible for oxidative phosphorylation. Mito‐
nuclear protein interactions have been shown to influence disease 
manifestation in some cases (Loewen & Ganetzky, 2018), and it has 
been suggested that supernumerary nuclear proteins could mask 
certain pathogenic mutations by stabilizing the protein complexes 
(Mimaki, Wang, McKenzie, Thorburn, & Ryan, 2012). It might also 
be related to differential selective pressure on mt‐protein‐encoding 
genes and mt‐tRNA genes during the formation of primordial germ 
cells.
To expand our understanding of sequence context on the ex‐
pression and penetrance of mitochondrial mutation, this study aims 
to continue the work of Queen et al. (2017) by identifying whether 
pathogenic point mutations are present in the remaining 21 tRNA 
genes and how the pathogenic effect seen in humans is suppressed.
2  | MATERIAL S AND METHODS
2.1 | Multiple sequence alignment generation and 
quality control
Queen et al. (2017) previously compiled 2,784 mt‐tRNA sequences 
from 33 non‐human species GenBank records. These species were 
restricted to the Chordata phylum; each species also required a 
minimum of 30 complete mitochondrial sequences in GenBank as 
part of the selection criteria. The mt‐tRNA gene sequences from 
the Revised Cambridge Reference Sequence (rCRS), NC_012920.1, 
were added to the corresponding non‐human species FASTA files. 
Multiple sequence alignments were produced from the FASTA files 
using the ClustalW alignment algorithm (Thompson, Higgins, & 
Gibson, 1994). All multiple sequence alignments were quality‐con‐
trolled. Sequences > 5 nucleotides longer or shorter than the rCRS 
were identified with a short script which uses the Biopython AlignIO 
module (Cock et al., 2009; O'Keefe, 2018). These sequences were 
then manually inspected and either removed or trimmed accordingly. 
Similarly, the script was also utilized to identify sequences with ≥5 
unknown bases (“N”). These sequences were then removed from the 
alignments.
2.2 | Variant scoring and analysis of the MitoTip 
scoring system
As the genomic location of the mt‐tRNA genes can vary between 
species, all variants refer to the nucleotide positions within the 
rCRS. Equivalent positions were identified within the species align‐
ments by their location within the individual genes. A list of human 
disease‐associated variants was compiled from the MitoMap da‐
tabase (Lott et al., 2013) [Accessed: 26‐05‐2018]. Each variant 
was scored for pathogenic status in accordance with the widely 
accepted Yarham et al. criteria (Yarham et al., 2011). FASTA se‐
quences for each of the mt‐tRNA genes were collected from the fol‐
lowing GenBank records: NC_012920, NC_001643, NC_001644, 
NC_005089, NC_001655.2, NC_006853, NC_001323, NC_002081 
and NC_002082.1. ClustalW alignments of the nine sequences for 
each mt‐tRNA gene were performed. The Biopython AlignIO mod‐
ule was used to assess conservation at the site of each disease‐as‐
sociated variant as part of the pathogenicity scoring criteria set 
forth by Yarham et al. (2011).
A search of the MitoMap database looked for each of the variants 
MitoTip pathogenicity predictions (Sonney et al., 2017) [Accessed: 
26‐05‐2018]. The pathogenicity predictions by MitoTip were com‐
pared with the pathogenicity status of each variant derived from the 
scoring system devised by Yarham et al. (2011). Furthermore, the 
conservation index and GenBank frequencies for each pathogenic 
mutation were queried using the MitoMaster SNV Query search tool 
(Lott et al., 2013) [Accessed: 08‐06‐2018].
2.3 | Variant search
A custom script was devised to search through the multiple se‐
quence alignments for specific positions that correspond to the list 
of disease‐associated variants derived from MitoMap. The script 
utilizes the Biopython AlignIO module and accounts for gaps in the 
human reference sequence by adjusting the variant position accord‐
ingly (O'Keefe, 2018). Pathogenic mutations are termed monomor‐
phic if they present ubiquitously across all sequences in the species 
in which they are identified. If the pathogenic mutations are pre‐
sented in some but not all individuals from ≥1 species, they are 
termed polymorphic.
2.4 | Secondary structure analysis and 
assessment of Watson‐Crick like base pairing
The mamit‐tRNA database was used to identify whether pathogenic 
mutations fell within a stem or loop of the mt‐tRNAs secondary 
structure and the corresponding base for each of the pathogenic 
mutations within the stem regions (Pütz, Dupuis, Sissler, & Florentz, 
2007). The maintenance of Watson‐Crick base pairing for those 
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within the stem regions was then assessed to identify changes at the 
corresponding base (O'Keefe, 2018).
2.5 | Assessment of tertiary structure interactions
Mt‐tRNAs have nine core tertiary interactions which contribute 
to the folding of the cloverleaf molecule (Sprinzl, Horn, Brown, 
Ioudovitch, & Steinberg, 1998). Each of the pathogenic mutations 
and any corresponding bases involved in Watson‐Crick like pairs 
were assessed to determine whether they are involved in one of 
these tertiary interactions. If so, the multiple sequence alignments 
were examined to identify any variation at the corresponding sites 
of these interactions (O'Keefe, 2018).
2.6 | Phylogenetic analysis and secondary 
structure modelling
We can investigate within‐species variability, by analysing pathogenic 
mutations where the minor allele arises in ≥5 individuals in any given 
species. Clades were determined by the collective polymorphic sites 
within the mt‐tRNA gene of the given species. Each clade and its fre‐
quency were then loaded into Network 4.6.1.6 for phylogenetic analy‐
sis (Bandelt, Forster, & Röhl, 1999). In addition, the sequence of each 
clade was modelled using the tRNA‐SE SCAN search server (Lowe & 
Chan, 2016). Sequence source was set to vertebrate mitochondria with 
search mode set as default. The models were used to identify population 
variants which have the potential to mask these pathogenic mutations. 
MitoMap was used to retrieve human mtDNA sequence records which 
contain the masking variants.
3  | RESULTS
A total of 726 multiple sequence alignment files, comprising 22 mt‐
tRNAs from each of the 33 species, were produced. Quality control 
was used to ensure the removal of poor‐quality sequences result‐
ing in the removal of 50 Sequences across 10 species (Queen et al., 
2017), see Table 1.
3.1 | Assessment of pathogenicity and 
MitoTip evaluation
The Yarham et al. (2011) system was used for each variant listed on 
MitoMap to gain an evidence‐based assessment of the likelihood 
of pathogenicity. MitoTip is a new feature of the MitoMap data‐
base that provides a pathogenicity estimate for mt‐tRNA variants 
(Sonney et al., 2017). The results given by MitoTip were compared 
with the scoring results of the Yarham et al. (2011). The Yarham et 
al. (2011) criteria scored 113 as definitely being pathogenic muta‐
tions. MitoTip predictions matched the definitely pathogenic sta‐
tus of 33 of these mutations, demonstrating ~29% sensitivity. Two 
variants scored as probably pathogenic but were not matched by 
MitoTip. A further 56 of the variants scored as possibly pathogenic 
in accordance with Yarham et al. (2011), and only 17 were matched 
by MitoTip. Finally, with Yarham et al. (2011) the remaining 100 
variants scored as neutral. MitoTip predicted 71 as neutral, dem‐
onstrating 71% specificity, Table 2. Overall, the results suggest 
that MitoTip is specific at the cost of some sensitivity.
3.2 | Pathogenic point mutations in non‐
human species
MitoMap lists 217 mt‐tRNA variants that have been associated 
with disease (Lott et al., 2013). As the assessment of pathogenicity 
shows, 113 of these are classified as definitely pathogenic muta‐
tions. Each of the species alignments was searched for the presence 
of any of these 217 variants. Across the 22 mt‐tRNA genes, 175 vari‐
ants presented as either polymorphic or monomorphic changes in 
≥1 species. Fifty‐eight of the changes seen are classed as definitely 
pathogenic mutations with 34 of these mutations being monomor‐
phic and 24 being polymorphic, Table 3. These 58 definitely patho‐
genic mutations are dispersed across 19 of the 22 mt‐tRNA genes. 
mt‐tRNA‐GLN, mt‐tRNA‐THR and mt‐tRNA‐TYR do not harbour 
any proven pathogenic mutations in these species. Interestingly, 
~82% of the monomorphic mutations arise in less than 10 species 
studied here and one, m.5703G > A, appeared in all primate species 
(Figure 1). This mutation has been associated with early‐onset dis‐
ease presenting as muscle weakness, ophthalmoplegia and a loss of 
subcutaneous fat, resulting in an emaciated physique (Vives‐Bauza 
et al., 2003). The MitoMaster SNV query tool searches 45,494 
full‐length sequences to produce a conservation index. This is the 
percentage of sequences which contain the same nucleotide as the 
rCRS at the query site (Lott et al., 2013). By consulting this, a clearer 
picture of conservation can be established. Table 4 demonstrates 
the conservation index and GenBank frequency of all 58 definitely 
pathogenic mutations seen in the non‐human species.
3.3 | Positions of pathogenic mutations and the 
maintenance of Watson‐Crick base pairing
Of the 58 pathogenic mutations found in the non‐human species, 
43 fall within the stem regions of their relative mt‐tRNAs and 15 
within the loop regions. The 43 variants within the stem regions 
were assessed for a Watson‐Crick like pairing. Two of these muta‐
tions fall within nonpairing regions, the D‐AC‐stem joint and the 
discriminator base. One position, m.3253, is ordinarily involved in 
a G:U Wobble pairing, and the remaining 40 stem mutations are in‐
volved in Watson‐Crick like pairings. The single G:U Wobble base 
pair is transformed to a Watson‐Crick like pairing by the patho‐
genic mutation, m.3253G > A, and no change is seen at the cor‐
responding base in any of the species. Watson‐Crick like pairing is 
maintained for 22 of the stem mutations by a change at the cor‐
responding base across all relevant species. A further seven muta‐
tions showed a change at the corresponding base in some but not 
all the relevant species. Finally, 11 of the mutations did not show 
any change at the corresponding base, Table 3.
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TA B L E  1   Number of sequences per species before and after quality control
Taxonomic order Species Common name
Number of sequences 
before QC
Number of sequences 
after QC
Primates Pan Paniscus Banobo 54 54
Pan Troglodytes Central Chimpanzee 56 54
Pan Troglodytes Schweinfurthii Easter Chimpanzee 33 33
Pan Troglodytes Verus Western Chimpanzee 30 30
Macaca Fascicularis Crab‐eating Macaque 44 44
Rodentia Mus Musculus Mouse 50 50
Mus Musculus Domesticus House Mouse 59 59
Rattus Norvegicus Brown Rat 66 66
Myodes Glareolus Bank Vole 35 35
Anguilliformes Anguilla Anguilla European Eel 55 55
Anguilla Rostrata American Eel 51 51
Artiodactyla Bos Taurus Cow 275 274
Bos Grunniens Yak 83 83
Ovis Aries Sheep 94 94
Clupeiformes Clupea Harengus Atlantic Herring 100 100
Salmoniformes Coregonus Lavaretus European Whitefish 80 80
Perissodactyla Equus Caballus Horse 247 244
Galliformes Gallus Gallus Red Jungle Fowl 66 65
Carcharhiniformes Glyphis Glyphis Speartooth Shark 94 94
Cypriniformes Hypophthalmichthys Molitrix Silver Carp 30 29
Hypophthalmichthys Nobilis Bighead Carp 36 35
Cetartiodactyla Balenoptera Physalus Fin Whale 154 148
Bison Bison Bison 34 34
Orcinus Orca Killer Whale 87 87
Sus Scrofa Wild Boar 150 131
Syncerus Caffer African Buffalo 45 45
Tursiops Truncatus Common Bottlenose Dolphin 50 50
Carnivora Canis Lupus Familiaris Dog 391 389
Urocyon Littoralis Catalinae Island Fox 41 41
Urocyon Littoralis Clementae Island Fox 33 33
Urocyon Littoralis Santacruzae Island Fox 42 42
Ursus Arctos Brown Bear 74 74
Ursus Spelaeus Cave Bear (Extinct) 34 20
TA B L E  2   MitoTip pathogenicity prediction versus the results of the Yarham et al scoring system
 
Yarham et al scoring
Pathogenic (113) Probably (2) Possibly (56) Neutral (100)
MitoTip prediction Pathogenic 33/113 2/2 2/56 0/100
Probably 23/113 0/2 16/56 8/100
Possibly 27/113 0/2 17/56 19/100
Neutral 26/113 0/2 19/56 71/100
No score 4/113 0/2 2/56 2/100
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TA B L E  3   (A) Mutations present in 100% of the sequences from one or more species. (B) Mutations that are polymorphic in one or more 
species
(A)
Monomorphic
Gene Mutation Stem
Secondary structure Tertiary interactions
WC Pair
Changed in 
species? Mutation WC Pair
Ala 5591G > A ACC 5652C > T Some – –
Arg 10450A > G T 10460T > A Some (13T > C‐22C > T)‐46A > G 56A > C‐19A
Asn 5703G > A T 5687C > T All – –
Asn 5728T > C ACC 5659A > G None – –
Asp 7554G > A AC 7544C > T None – –
Gly 10010T > C D 10002A > G None – –
His 12183G > A T 12197C > T All (13A‐22A)‐46G > A –
Ile 4267A > G ACC 4326T > C All – –
Ile 4269A > G ACC 4324T > C All – –
Ile 4274T > C D 4281A > G All – 56C > T‐19T > C
Ile 4281A > G D 4274T > C All 56C > T‐19A > G –
Ile 4300A > G AC 4286T > C All – –
Leu 3273T > C AC 3259A > G All 44T > C‐26C –
Leu 3302A > G ACC 3231T > C All – –
Leu2 12276G > A D 12288C > T None – 9G‐23C
Lys 8355T > C T 8339A > G Some – (25A > G‐10G)‐45A > G
Met 4403G > A ACC 4467C > T All – –
Phe 582T > C ACC 641A > G All – –
Phe 583G > A ACC 640C > T All – –
Phe 602C > T D 586G > A None 44A‐26C > T (25C‐10C)‐45G
Phe 617G > A AC 607C > T None – –
Pro 15967G > A T 15975C > T Some – –
Ser 7497G > A D 7503C > T All – 58A‐54C
Ser 7511T > C ACC 7450A > G None – –
Ser 7512T > C ACC 7449A > G All – –
Trp 5538G > A AC 5552C > T All – –
Val 1606G > A ACC 1665C > T All – –
Val 1624C > T D 1611G > A None 9A‐23C > T (25C > T‐10G)‐45T
Val 1630A > G AC 1638T > C All – –
Monomorphic
Gene Mutation Loop Tertiary interaction
Asn 5709T > C D –
Cys 5814T > C D –
Leu 3251A > G D (13G‐22A > G)‐46C > T
Ile 4302A > G VARIABLE REGION –
Trp 5556G > A VARIABLE REGION (25A‐10G)‐45G > A
(Continues)
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3.4 | Variability in bases involved in the nine tertiary 
interactions
The cloverleaf structure of mt‐tRNAs undergoes a tertiary folding 
pattern to become an L‐shaped 3D molecule. In order to achieve 
this, nine long‐range folding interactions are required (Helm et al., 
2000). Involvement in these tertiary interactions was noted for each 
of the pathogenic mutations and any corresponding bases involved 
in Watson‐Crick like pairing. Sixteen of the pathogenic mutations 
and nine of the corresponding Watson‐Crick like bases are involved 
in tertiary interactions. Therefore, a total of 25 tertiary interactions 
were explored to identify changes at the other sites. Eleven cases 
showed further changes; however, in six of the cases, the changes 
were only seen in some of the relevant species. Furthermore, 13 
cases showed no changes at the additional sites, Table 3.
3.5 | Phylogenetic analysis and secondary 
structure modelling
Eight genes held a single pathogenic mutation where the minor allele 
was present in at least five individuals in any given species, Table 5. 
One of these was the m.3243A > G in the mt‐tRNA‐LEU(UUR) gene. 
As Queen et al. (2017) have already investigated this mutation and 
gene in detail, it was not considered for further analysis. The poly‐
morphic mutations across the remaining seven genes were taken for‐
ward for analysis. The multiple sequence alignments of each of the 
species containing the polymorphic mutations were subdivided into 
clades according to the total polymorphic variability within the gene. 
Each of these clades was modelled to demonstrate the impact of 
the total nucleotide variability on the secondary structure of the mt‐
tRNAs (Bandelt et al., 1999; Lowe & Chan, 2016). Three pathogenic 
(B)
Polymorphic
Gene Mutation Stem
Secondary structure Tertiary interactions
WC Pair
Changed in 
species? Mutation WC Pair
Ala 5628T > C AC 5620A > G None – –
Ala 5650G > A ACC 5593C > T None – –
Glu 14739G > A ACC 14678C > T All – –
Glu 14674T > C DETERMINATOR – – – –
Ile 4284G > A D–AC – – (13G‐22G > A)‐46G > A –
Ile 4309G > A T 4321C > T All – –
Leu 3253T > C D 3242G > A None – –
Leu 3271T > C AC 3261A > G All – –
Lys 8342G > A T 8352C > T None 48G > A‐15C > T 58C‐54A > T
Lys 8356T > C T 8338A > G Some – 44A‐26C
Phe 642T > C ACC 581A > G All – –
Ser2 12261T > C ACC 12210A > G Some 55T > C‐18T –
Ser2 12264C > T ACC 12207G > A Some 58C > T‐54T > C –
Trp 5540G > A AC 5550C > T All – –
Polymorphic
Gene Mutation Loop Tertiary interaction
Asn 5693T > C ANTI‐CD –
Glu 14687A > G T (8T > A‐14A > G)‐21C
Glu 14709T > C ANTI‐CD –
Glu 14728T > C D 55T > C‐19A > C
Leu 3243A > G D (8G‐14A > G)‐21A
Leu 3244G > A D –
Lys 8344A > G T –
Phe 622G > A VARIABLE REGION (13A‐22A)‐46G > A
Ser 7472A > C VARIABLE REGION –
Val 1644G > A VARIABLE REGION –
TA B L E  3  (Continued)
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mutations are of significant interest: m.5650G > A, m.8344A > G 
and m.1644G > A in mt‐tRNA‐Ala, mt‐tRNA‐Lys and mt‐tRNA‐Val, 
respectively, (Figures 2‒5) with data from other mutations being 
shown as (Figures S1–S4).
F I G U R E  1   All pathogenic mutations presenting in 100% of the sequences for every species in which they are identified are classified in 
this study as monomorphic mutations
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3.6 | m.5650G > A mt‐tRNA‐Ala
The m.5650G > A mutation is associated with Myopathy 
(McFarland et al., 2008). The MitoMaster SNV query tool re‐
vealed that the conservation index for this position is 64.44% 
and a single GenBank record from a disease report is available, as 
shown in Table 4 (Annunen‐Rasila et al., 2006; Lott et al., 2013). 
This mutation is present in 118 of the Sus scrofa sequences stud‐
ied here. It is also present monomorphically and as a low fre‐
quency polymorphism in other species, as shown in Table 5. The 
Sus scrofa alignment showed a further six polymorphic positions 
which, along with m.5650, were used to determine the clades. 
In addition to this, 10 positions were monomorphically divergent 
from the rCRS. Eleven clades were drawn from the alignment, 
eight of which contained m.5650G > A. The adjoining monomor‐
phic variant, m.5651C > T, contains a base pairing of A:T trans‐
formed from G:T in all Sus scrofa sequences. This may stabilize 
the conformation in that region and act to mask the pathogenic 
effects of m.5650G > A (Figure 2). In GenBank, a single human 
mitochondrial sequence record, which belongs to haplogroup L1c, 
contains m.5651T.
3.7 | m.8344A > G mt‐tRNA‐Lys
The m.8344A > G mutation is particularly interesting as this is 
the primary mutation for Myoclonic Epilepsy with Ragged Red 
Fibres (MERRF). It is thought to account for ~80% of all MERRF 
cases and is the second most common pathogenic point muta‐
tion in mitochondrial disorders after m.3243A > G (Lorenzoni, 
Scola, Kay, Silvado, & Werneck, 2014). MitoMasters SNV query 
tool showed the conservation index is relatively low at 37.78% 
(Lott et al., 2013). Only four entries are available in GenBank 
TA B L E  4   Conservation index and GenBank frequency of the 58 
Mutations found amongst these 33 species
Gene Position Mutation
Conservation 
index (%)
GenBank 
frequency
Ala 5,591 G > A 91.11 0
5,628 T > C 95.56 88
5,650 G > A 64.44 1
Arg 10,450 A > G 91.11 0
Asn 5,693 T > C 100 0
5,703 G > A 8.89 0
5,709 T > C 80 0
5,728 T > C 86.67 1
Asp 7,554 G > A 91.11 1
Cys 5,814 T > C 75.56 128
Glu 14,674 T > C 73.33 7
14,687 A > G 88.89 267
14,709 T > C 95.56 1
14,728 T > C 91.11 0
14,739 G > A 71.11 0
Gly 10,010 T > C 100 0
His 12,183 G > A 71.11 1
Ile 4,267 A > G 93.33 0
4,269 A > G 86.67 0
4,274 T > C 95.56 0
4,281 A > G 100 1
4,284 G > A 62.22 2
4,300 A > G 93.33 0
4,302 A > G 97.78 0
4,309 G > A 24.44 1
Leu 3,243 A > G 97.78 9
3,244 G > A 95.56 6
3,251 A > G 93.33 0
3,253 T > C 84.44 6
3,271 T > C 82.22 0
3,273 T > C 97.78 0
3,302 A > G 91.11 0
Leu2 12,276 G > A 97.78 1
Lys 8,342 G > A 62.22 0
8,344 A > G 37.78 4
8,355 T > C 68.89 0
8,356 T > C 26.67 0
Met 4,403 G > A 97.78 1
Phe 582 T > C 80 0
583 G > A 95.56 0
602 C > T 97.78 0
617 G > A 97.78 0
622 G > A 93.33 0
642 T > C 91.11 0
(Continues)
Gene Position Mutation
Conservation 
index (%)
GenBank 
frequency
Pro 15,967 G > A 35.56 0
Ser 7,472 A > C 62.22 3
7,497 G > A 8.89 1
7,511 T > C 91.11 1
7,512 T > C 31.11 0
Ser2 12,261 T > C 88.89 0
12,264 C > T 71.11 0
Trp 5,538 G > A 86.67 0
5,540 G > A 95.56 0
5,556 G > A 93.33 0
Val 1,606 G > A 71.11 0
1,624 C > T 97.78 0
1,630 A > G 15.56 0
1,644 G > A 91.11 0
Note: Derived from the MitoMaster SNV Query tool.
TA B L E  4   (Continued)
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TA B L E  5   Mutations arising polymorphically in one or more species
Gene Mutation Monomorphic Polymorphic
Ala 5628T > C Anguilla anguilla, Anguilla rostrata, Clupea harangus, Coregonus 
lavaretus
Balaenoptera physallis (1/148)
Ala 5650G > A Balaenoptera physallis, Bison bison, Bos gruniens, Bos taurus, 
Coregonus lavaretus, Glyphis glyphis, Myodes glareolus, Oricnus 
orca, Ovis aries, Rattus norvegicus, Syncerus caffer, Tursiops 
truncatus
Anguilla anguilla (2/55), Sus scrofa (118/131), Ovis 
aries (93/94)
Asn 5693T > C – Sus scrofa (1/131)
Glu 14739G > A Anguilla anguilla, Anguilla rostrata, Clupea harangus, Macaca 
fascicularis, Mus musculus, Mus musculus domesticus, Rattus 
norvegicus
Myodes glareolus (2/35)
Glu 14674T > C Ovis aries Macaca fascicularis (27/44)
Glu 14687A > G – Canis lupus familiaris (2/389)
Glu 14709T > C Clupea harangus Myodes glareolus (33/35)
Glu 14728T > C Gallus gallus Myodes glareolus (33/35)
Ile 4284G > A Gallus gallus, Glyphis glyphis, Hypophthalmichthys nobilis, 
Hypophthalmichthys molitrix, Oricnus orca, Pan paniscus, Pan 
trogolodytes trogolodytes, Pan trogolodytes schweinfurthii, Pan 
trogolodytes verus, Ursus arctos, Ursus spelaeus
Clupea harangus (2/100), Coregonus lavaretus 
(7/80), Mus musculus domesticus (58/59), 
Syncerus caffer (1/45), Tursiops truncatus (1/50)
Ile 4309G > A Balaenoptera physallis, Bison bison, Bos gruniens, Bos taurus, 
Equus caballus, Macaca fascicularis, Mus musculus domesticus, 
Myodes glareolus, Oricnus orca, Ovis aries, Rattus norvegicus, 
Sus scrofa, Syncerus caffer, Tursiops truncatus, Urocyon litteralis 
clementae, Urocyon litteralis catalinae, Urocyon litteralis san‐
tacruzae, Ursus arctos, Ursus spelaeus
Canis lupus familiaris (386/389), Clupea harangus 
(99/100), Mus musculus (48/50)
Leu 3253T > C Canis lupus familiaris Macaca fascicularis (8/44)
Leu 3271T > C Anguilla rostrata, Coregonus lavaretus, Gallus gallus, Glyphis gly‐
phis, Hypophthalmichthys nobilis, Hypophthalmichthys molitrix, 
Mus musculus domesticus, Myodes glareolus, Rattus norvegicus
Anguilla anguilla (54/55)
Leu 3243A > G – Canis lupus familiaris (57/389)
Leu 3244G > A – Ursus arctos (2/74)
Lys 8342G > A Ovis aries, Ursus arctos Macaca fascicularis (44/44), Sus scrofa (1/131)
Lys 8356T > C Balaenoptera physallis, Bos taurus, Coregonus lavaretus, Equus 
caballus, Hypophthalmichthys nobilis, Hypophthalmichthys mo‐
litrix, Mus musculus domesticus, Myodes glareolus, Oricnus orca, 
Rattus norvegicus, Sus scrofa, Syncerus caffer, Ursus spelaeus
Anguilla anguilla (1/55)
Lys 8344A > G Ursus arctos Ovis aries (9/94), Pan paniscus (3/54), Pan trogolo‐
dytes verus (9/30), Sus scrofa (130/131), Syncerus 
caffer (1/45)
Phe 642T > C Clupea harangus, Coregonus lavaretus, Glyphis glyphis, 
Hypophthalmichthys nobilis, Hypophthalmichthys molitrix
Gallus gallus (2/65)
Phe 622G > A – Balaenoptera physallis (2/148)
Ser 7472A > C Balaenoptera physallis, Equus caballus, Gallus gallus, Oricnus orca, 
Sus scrofa, Tursiops truncatus
Ovis aries (1/94)
Ser2 12261T > C Clupea harangus, Gallus gallus, Hypophthalmichthys nobilis, 
Hypophthalmichthys molitrix
Macaca fascicularis (27/44)
Ser2 12264C > T Bos gruniens, Gallus gallus, Mus musculus domesticus, Myodes 
glareolus, Rattus norvegicus
Balaenoptera physallis (1/148), 
Hypophthalmichthys nobilis (2/29), 
Hypophthalmichthys molitrix (2/35)
Trp 5540G > A Coregonus lavaretus Oricnus orca (53/87)
Val 1644G > A Glyphis glyphis Macaca fascicularis (27/44), Myodes glareolus 
(1/35)
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for this mutation, one from a disease report and three from 
population studies, as shown in Table 4 (Kutanan et al., 2018; 
Mishmar et al., 2003; Neparáczki et al., 2017; Zsurka et al., 
2007). Nine individuals from Ovis aries and nine individuals 
from Pan troglodytes verus harbour this mutation. It is also seen 
as a monomorphism, near monomorphism or low frequency 
polymorphism in other species, Table 5. The Ovis aries align‐
ments were polymorphic at another seven sites and diverged 
monomorphically from the rCRS at 19 sites. The alignment 
subdivided into nine clades, with a single clade containing 
m.8344A > G. Variation can be seen at ±2 positions of m.8344 
and a conversion of G‐C pair to A‐T pair is seen at the final base 
of the T‐stem (Figure 3). The Pan troglodytes verus alignments 
diverged monomorphically from the rCRS at one site and had 
polymorphic variation at a further two sites, in close proximity 
to m.8344. This divided the alignment into four clades, with 
just one clade showing the m.8344A > G mutation (Figure 4). 
In both species, there is an m.8310T > C variant in the D‐loop. 
GenBank holds nine human mitochondrial sequences contain 
m.8310C. These sequences belong to haplogroups J1c, L2a, C, 
Q1a, T2b and M5a.
3.8 | m.1644G > A mt‐tRNA‐Val
Macaca fascicularis exhibited the m.1644G > A mutation in 27 in‐
dividuals. It is in two other species as a monomorphism and low 
frequency polymorphism, Table 5. This mutation is associated with 
MELAS (Tanji et al., 2008). The conservation index for this position 
is 91.11%, and no entries of this mutation are present in GenBank 
(Table 4; Lott et al., 2013). The presence of eight polymorphic sites 
alongside m.1644 meant this species alignment was subdivided 
into 10 clades with four clades containing m.1644G > A. There 
is also monomorphic divergence from the rCRS at 16 positions in 
Macaca fascicularis. The adjoining position m.1643 is one of the 
polymorphic sites. This site is intriguing as the polymorphism co‐
incides with the m.1644 mutation. Between the two sites, G‐A 
coupling is always maintained, suggesting it may be structurally 
important. In GenBank, one human mitochondrial sequence from 
haplogroup H1u contains m.1643G. There is also a loss of the near‐
est Watson‐Crick like pair at the AC‐stem in all clades, which ex‐
tends the length of the D‐AC‐stem joint and the variable region by 
one base (Figure 5).
To summarize, extensive evidence of the important of sequence 
context has been presented. The results are also presented as a single 
excel supplementary table. This table contains all the variants consid‐
ered as part of this study with the results from the three different algo‐
rithms applied to score the pathogenicity, the Yarham method (Yarham 
et al., 2011), MitoTIP (Sonney et al., 2017) and MitoMaster SNV (Lott et 
al., 2013). The table also includes information on whether the variants 
are monomorphic and polymorphic in the named species. Importantly, 
information as to whether the variants are predicted to affect second‐
ary and tertiary interactions is given, see Supplemental Tables.xlsx.
4  | DISCUSSION
A study of South African paediatric patients showed the preva‐
lence of known pathogenic mtDNA mutations was ~1% (van der 
Walt et al., 2012; van der Westhuizen et al., 2015), suggesting 
there is still work to be done in understanding mtDNA disease 
globally. We investigated the effect of mitochondrial sequence 
context by identifying known pathogenic mutations in species 
from the Chordata phylum. Animals have been shown to suffer 
from mtDNA disorders. Baranowska et al. investigated a family 
of Golden Retrievers with Sensory Ataxic Neuropathy. Results in‐
dicated that m.5304del on mt‐tRNA‐Tyr, equating to m.5848 in 
humans, had caused the disorder in the dogs (Baranowska et al., 
2009). Understanding how pathogenic point mutations exist with‐
out a disease phenotype in other species may explain diagnostic 
variability, and lead to mechanistic insights. This paper highlights 
the importance of sequencing the whole mtDNA from patients es‐
pecially those from less studied groups.
The secondary and tertiary folding patterns of mt‐tRNAs are well 
recognized. Watson‐Crick like interaction is necessary for the for‐
mation of the cloverleaf secondary structure. Queen et al. (2017) 
noted that known mutations falling within the stem regions of the 
mt‐tRNA cloverleaves often presented with a second change at the 
corresponding base, which should maintain the Watson‐Crick like 
interactions. In the current study, this phenomenon is seen with ap‐
proximately half of the pathogenic mutations that arise in the stems 
(Table 3). It is thought that the disruption to the Watson‐Crick like 
bond is responsible for the manifestation of disease rather than the 
specific variant (McFarland, Elson, Taylor, Howell, & Turnbull, 2004). 
There are nine core tertiary interactions that are important for cor‐
rect folding of the mt‐tRNAs into the canonical L‐shape (Helm et 
al., 2000). Each of the 58 pathogenic point mutations and the 41 
corresponding bases in the stems were assessed for their involve‐
ment in tertiary interactions (Table 3). It is important to consider 
the corresponding bases in the stems as any involvement in ter‐
tiary interactions may be dominant over maintaining the secondary 
structure bonds. Approximately 25% of the 99 sites were involved in 
one of the nine interactions, just over half of which showed further 
changes at the other sites (Table 3). Leontis–Westhof classification 
states that there are 12 possible interactions between nucleotides 
in an RNA molecule, six trans and six cis conformations. These bonds 
are determined by the Hoogsteen, Sugar and Watson‐Crick edges 
of the nucleotides . It is thought that the 12 bonding patterns are 
interchangeable without disrupting the tertiary structure (Leontis & 
Westhof, 2001). Therefore, when a variant arises it may not be det‐
rimental to the formation of the mt‐tRNAs L‐shape. It is also possi‐
ble that changes at other sites of the tertiary interaction could mask 
pathogenic point mutations by exchanging bonding patterns.
Polymorphic point mutations allow the exploration of within‐
species variability. Further analysis was performed for species where 
the minor allele arises in at least five individuals (Table 5). Three of 
the pathogenic point mutations were of particular of interest as they 
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arise in species that have substantial sequence variability to define 
multiple clades.
Variants within mt‐tRNA‐Ala have been associated with isolated 
myopathy. Isolated myopathy presents as pure muscle weakness with 
variable age of onset (Lehmann et al., 2015). One pathogenic point 
mutation which causes this condition is m.5650G > A. As mt‐tRNA‐
Ala is encoded on the heavy strand of the mitochondrial genome, 
all sequences, variants and mutations refer to the tRNA molecules 
complement sequence. Therefore, m.5650G > A is equal to a C > U 
change in the tRNA molecule itself. This mutation is polymorphic at 
high frequency within Sus scrofa, Table 5. There is monomorphic and 
polymorphic variability throughout the Sus scrofa mt‐tRNA‐Ala align‐
ment, which could potentially contribute to masking m.5650G > A 
(Figure 2). One variant of interest, m.5651C > T, is present at the 
adjoining site in 100% of sequences. m.5651 forms part of the G:U 
Wobble pair that acts as the synthetase recognition site. G:U Wobble 
pairs give conformational flexibility within the backbone of mt‐tRNA 
molecules (Varani & McClain, 2000). Previous studies in Escherichia 
coli have shown that alteration of the G:U Wobble pair to an A:U 
pair, as seen here (Figure 2), lowers the recognition sites binding af‐
finity but increases the stability of the backbone (). The pathogenic 
mutation, m.5650G > A, gives rise to a U:G Wobble pair. The angle 
of U:G Wobble pairs is ~2 Å different to G:U Wobble pairs and, be‐
cause these sites are adjoining, the small difference in angle may be 
enough to abate the loss of binding affinity (Masquida & Westhof, 
2000). It is plausible that this change has allowed m.5650G > A to 
arise without disease.
The two most commonly seen point mutations in patients with 
mitochondrial disorders are m.3243A > G in the D‐loop of mt‐
tRNA‐Leu(URR) and m.8344A > G in the T‐loop of mt‐tRNA‐Lys. 
These variants are assoctiated with the MELAS and MERRF syn‐
dromes, respectively (Yarham, Elson, Blakely, McFarland, & Taylor, 
2010). Myoclonic Epilepsy with Ragged Red Fibres is a highly de‐
bilitating disorder that presents primarily as ataxia, progressive 
spasmodic seizures and an accumulation of abnormal mitochon‐
dria under the sarcolemmal membrane of skeletal muscle fibres 
(Brinckmann et al., 2010; Lorenzoni et al., 2014). In all mt‐tRNAs, 
with the exception of mt‐tRNA‐Ser (AGY), the T‐loop is involved 
in long‐range tertiary interactions with the D‐loop to create the 
elbow of the L‐shaped structure. This elbow is important for rec‐
ognition of post‐transcriptional modifiers and undergoes heavy 
modifications itself (Lorenz, Lünse, & Mörl, 2017). Interestingly, 
both m.8344A > G and m.3243A > G result in a loss of post‐tran‐
scriptional Uridine modification, τm5s2U34 and τm5U34, at the 
first wobble base of the anticodon (Yasukawa et al., 2000). A 
subset of Ovis aries and Pan troglodytes verus sequences contain 
m.8344A > G, Table 5. In both species, further variation is seen 
within the T‐loop and there is a T > C change at m.8310 within 
the D‐loop (Figures 3 and 4). Furthermore, in Ovis aries the T‐loop 
is truncated to seven bases and the G:C pair at the terminal of the 
T‐stem is transformed to an A:U pair (Figure 2). Similarly, Queen et 
al. (2017) found m.3243A > G in a selection of Canis lupus familiaris 
sequences with adaptation of a G:U wobble pair to a G:C pair at 
the terminal of the D‐stem. It is plausible that variation in either 
loop and at the terminal bases of the stems could stabilize the con‐
formation of the elbow by reacting with local post‐transcriptional 
modifications. Stabilizing the tertiary structure would allow nor‐
mal modification of the anticodon Uridine, masking the pathogenic 
phenotype in these species. Patients with m.8344G can present 
with deposits of brown adipose tissue around the back of the 
neck. These kinds of deposits are also common in neonates and 
hibernating species as a means of regulating body temperature. 
There is potential that m.8344G has arisen in response to the ther‐
moregulatory needs of these species. Sequence context would be 
important in mitigating the negative phenotypes that can occur 
with this mutation for it to be beneficial.
The phenotypic manifestations of MELAS include neurode‐
generation, myopathy, seizures, stroke‐like episodes and a build‐
up of lactic acid (El‐Hattab, Adesina, Jones, & Scaglia, 2015). 
m.1644G > A in the variable region of mt‐tRNA‐Val has been re‐
ported as a cause of MELAS. Interestingly, a G > T change at this 
site is reported to cause Leigh's syndrome (Chalmers et al., 1997). 
This demonstrates that whilst the position of the variant may de‐
termine whether a disease arises, the particularities of the nucle‐
otide substitution can determine the phenotypic manifestation of 
disease. In mt‐tRNAs, the variable region interacts with the D‐loop 
to form the core of the elbow and aids synthetase recognition. 
Post‐transcriptional modifications within this region contribute to 
both the stability and flexibility of the tertiary structure (Torres, 
Batlle, & Ribas de Pouplana, 2014). The m.1644G > A mutation is 
seen in a selection of Macaca fascicularis sequences, Table 5. In all 
Macaca fascicularis sequences, there is a loss of the Watson‐Crick 
like C:G pair at the terminal of the AC‐stem, truncating the stem to 
4 base pairs (Figure 5). The one base elongation of the D‐AC‐stem 
joint and variable region, caused by this pairing loss, would alter 
the tertiary structure of mt‐tRNA‐Val, possibly abating the patho‐
genicity of m.1644G > A. Perhaps of more interest is the adjoining 
base, m.1643. This site presents a polymorphic A > G change in 
Macaca fascicularis sequences. These two changes, m.1644G > A 
and m.1643A > G, coincide with each other throughout the species, 
meaning an A,G or G,A couple is always seen at these positions 
(Figure 5). This suggests that the angle these nucleotides create 
F I G U R E  2   Phylogenetic analysis and secondary structure modelling of Sus scrofa mt‐tRNA‐Ala. Polymorphic variability in the Sus scrofa 
sequences divides the alignment into 11 clades. The phylogenetic network demonstrates the clades with and without the m.5605G > A 
mutation, drawn using NETWORK 4.6.0.6. As mt‐tRNA‐Ala is encoded on the heavy strand of the mitochondrial genome, all sequences and 
variants are denoted as the complement to the mtRNA molecule. These differences can be seen between the alignment of the clades and 
the secondary structure models here. Secondary structure analysis demonstrates m.5650G on the Human rCRS and its G > A change in 
group 5 of Sus scrofa. The adjoining G:U wobble pair in the rCRS and its change to an A:U Watson‐Crick like pair in Sus scrofa is also noted
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F I G U R E  4   Phylogenetic analysis and secondary structure modelling of Pan troglodytes verus mt‐tRNA‐Lys. Four clades were derived 
from the alignment, based on polymorphic variation. The phylogenetic network demonstrates clades with and without m.8344A > G. 
Secondary structure modelling of the human rCRS and group 1 Pan troglodytes verus sequences demonstrate the m.8344A > G and 
m.8310T > C
F I G U R E  3   Phylogenetic analysis and secondary structure modelling of Ovis aries mt‐tRNA‐Lys. Nine clades were derived from 
polymorphic variability within the alignment. The phylogenetic network demonstrates the clades with and without the m.8344A > G 
mutation. Secondary structure modelling of the rCRS demonstrates m9344A in the T‐loop, the C:G Watson‐Crick like pair at the terminal of 
the T‐stem and m.8310T in the D‐Loop. Similarly, modelling of the Ovis aries group 2 sequences demonstrates m.8344A > G, a change from 
C:G to A:U Watson‐Crick like pairing at the terminal of the T‐stem and m.8310T > C
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may be structurally significant. By presenting the two together 
and maintaining this angle, the deleterious effects of m.1644G > A 
might be masked.
We considered the distribution of the potential masking variants, 
m.5651T, m.8310C and m.1643G, in human mtDNA sequences. 
MitoMap currently holds 46,092 full‐length human mtDNA sequences 
F I G U R E  5   Phylogenetic analysis and secondary structure modelling of Macaca fascicularis mt‐tRNA‐Val. Polymorphic variability within the 
M. fascicularis alignment subdivided the sequences into 10 clades. The phylogenetic network, created with NETWORK 4.6.1.6, demonstrates 
clades with and without m.1644G > A. Secondary structure modelling indicates m.1644G and m.1643A in the rCRS and the m.1644G > A and 
m.1643A > G changes in M. fascicularis, along with the loss of the C:G Watson‐Crick like pairing at the terminal of the AC‐stem
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from GenBank [Accessed: August 2018]. We used MitoMap to deter‐
mine which, if any, haplogroups these masking variants arise in. Both 
m.5651T and m.1643G arise in only a single sequence from hap‐
logroups L1c and H1u, respectively. Interestingly, m.8310C occurs 
in nine sequences, most commonly in Asian and African haplogroups. 
This reiterates the importance of considering sequence context when 
looking at mtDNA mutations, particularly in understudied populations.
We noted that in these species, quite often the nearest stem pair is 
modified in some way (Figures 2, 3, and 5), as seen with m.3243A > G 
by Queen et al. (2017). Kern and Kondrashov noted also that stem pairs 
nearby are often modified and indirectly stabilize the pathogenic muta‐
tion where they are seen in the absence of disease (Kern & Kondrashov, 
2004). Whilst these mechanisms of masking pathogenicity are specu‐
lation at this stage, it gives support to the theory that the sequence 
context of some haplogroup lineages can influence the manifestation of 
disease. It is interesting that the two most studied pathogenic mt‐tRNA 
point mutations, m.3243A > G and m.8344G > A, are found as poly‐
morphic variants in these species. We now know these human disease‐
causing mutations are population variants in other mammals (Queen 
et al., 2017). This provides motivation for investigating the occurrence 
and effects of common pathogenic point mutations in understudied 
populations. For a long time, it has been believed that if a variant is a 
haplogroup marker then it is not a candidate for being the causative 
variant in a patient. Perhaps we need to be open to there being some 
exceptions to this rule, especially if the variants are predicted to be del‐
eterious (Lott et al., 2013; Sonney et al., 2017). Sequencing studies of 
individuals from these understudied populations would help expand 
our knowledge of population variation and identify whether certain 
variants cause deleterious effects on specific lineages.
Others have also looked at human lineages in an attempt to under‐
stand the distribution of mtDNA mutations. Wei et al looked at 30,506 
complete human sequences suggesting an importance of mtDNA back‐
ground, or haplogroup context in the penetrance of disease. Their data 
suggested disease‐causing mutations were more frequent in young se‐
quences, or lineages (Wei, Gomez‐Duran, Hudson, & Chinnery, 2017). 
Similar observations have been reported in the past (Howell et al., 2007); 
however, other papers presented evidence to suggest all branches of the 
human phylogeny have been subject to the same level of purifying se‐
lection (Pereira, Soares, Radivojac, Li, & Samuels, 2011). This raises the 
question of the speed at which purifying selection takes place at the pop‐
ulation level. The timeframe of this process has been a long‐standing area 
of debate with ramifications on the use of mtDNA as a molecular clock 
to study population histories (Howell et al., 2007; Howell, Howell, & 
Elson, 2008). The ages of the lineage in such studies are calculated using 
the number of differences seen in the sequences in question compared 
with the reference sequence the rCRS or revised Cambridge reference 
sequence. The reference sequence is a European sequence; thus, the age 
of lineages calculated by this method is dependent on the location of 
the sequence in question compared with the reference sequence. If the 
reference sequence had been at a different location different lineages 
would be deemed to be young/old, this has been highlighted by Behar et 
al. (2012). It was suggested that a change in reference sequence to a hy‐
pothesized most recent common ancestor (MRCA) of all modern humans 
to help avoid such confusion in the context of the “age” of a lineage. 
Others however argued that any such change would instigate confusion 
in the database that would impact negatively on the medical and forensic 
fields (Bandelt, Kloss‐Brandstätter, Richards, Yao, & Logan, 2014).
It is worth highlighting that compensatory nuclear DNA variants 
for mtDNA mutations of Complex I have also been seen in other spe‐
cies. The interdependent nature of mito‐nuclear proteins means nu‐
clear variability, particularly in the supernumerary subunits, is likely 
to be able to resolve stability within the protein complexes (Mimaki et 
al., 2012). The work of Loewen and Ganetzky (2018) is an important 
exemplar when considering nuclear mitochondrial interactions. Their 
paper showed that that the phenotypic severity of a complex 1 mu‐
tation causing Leigh syndrome phenotype varies depending on the 
maternally inherited mitochondrial background. Leigh syndrome is a 
severe disorder characterized by early, progressive neurodegenera‐
tion, with both intellectual and motor difficulties, and deficient mi‐
tochondrial respiration (Lake, Compton, Rahman, & Thorburn, 2016).
For a long time, the presence of a variant as a haplogroup marker 
excluded it as a candidate for disease (Schon, Bonilla, & DiMauro, 1997). 
The data presented here and other data (Queen et al., 2017; Smuts et 
al., 2010) suggest out of place haplogroup markers sometimes called 
“private variants” should be considered as candidates and investigated 
using defined approaches (Yarham et al., 2011). In summary, studies 
such as the one presented here will allow us to gain a greater sense of 
the impact of mutations on tertiary structure and improve mechanistic 
understanding. They suggest there is clinical as well as anthropological 
motivation to continue to learn about mtDNA variation in populations 
where the mtDNA phylogeny is less well known. This knowledge might 
be essential to the diagnosis of disease (van der Westhuizen et al., 2015), 
which will be required if cutting edge therapies are to be offered to all 
population groups (Meldau et al., 2016). Certainly, this study reiterates 
that researchers and clinicians should not consider variants in isolation.
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